China sees huge bounce in pharma rankings ahead of hybrid CPhI & P-MEC China

China is the pharma industry’s biggest gainer in the 2021 CPhI Annual Rankings, with digital matchmaking driving new waves of partnerships
SHANGHAI , Nov. 18, 2021 /PRNewswire/ — China’s pharma industry has seen a record improvement in its overall score, growth potential and biologics according to new data.

Read the source article at Yahoo Finance
2021-11-18 07:00:00